| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 10, 2025 | Dec 11, 2025 | Ultragenyx Pharmaceutical Inc. | CFO | Sell | 22.5 | -3,081 | -3.14% | ✗ | $112.1K |
| Oct 13, 2025 | Oct 14, 2025 | Ultragenyx Pharmaceutical Inc. | CFO | Sell | 40.0 | -7,942 | -7.48% | ✗ | $250.3K |
| Mar 6, 2025 | Mar 10, 2025 | Ultragenyx Pharmaceutical Inc. | CFO | Sell | 42.5 | -1,785 | -1.65% | ✗ | $72.1K |
| Oct 10, 2024 | Oct 11, 2024 | Ultragenyx Pharmaceutical Inc. | CFO | Sell | 40.0 | -7,465 | -7.48% | ✗ | $393.9K |
| Feb 23, 2023 | Feb 24, 2023 | Vir Biotechnology, Inc. | CFO | Sell | 45.0 | -2,248 | -0.96% | ✗ | $58.4K |
| Feb 17, 2023 | Feb 21, 2023 | Vir Biotechnology, Inc. | CFO | Sell | 42.5 | -2,424 | -1.03% | ✗ | $61.3K |
| Feb 17, 2022 | Feb 22, 2022 | Vir Biotechnology, Inc. | CFO | Sell | 42.5 | -2,393 | -1.18% | ✗ | $76.4K |
| Jul 13, 2020 | Jul 15, 2020 | Vir Biotechnology, Inc. | CFO | Sell | 20.0 | -30,000 | -14.44% | ✓ | $1.5M |
| Jul 1, 2020 | Jul 2, 2020 | Vir Biotechnology, Inc. | CFO | Sell | 26.3 | -20,000 | -8.78% | ✓ | $778.4K |
| Jun 25, 2020 | Jun 26, 2020 | Vir Biotechnology, Inc. | CFO | Sell | 20.0 | -30,000 | -11.64% | ✓ | $1.5M |
| Jun 19, 2020 | Jun 23, 2020 | Vir Biotechnology, Inc. | CFO | Sell | 35.0 | -10,000 | -3.73% | ✓ | $400K |
| Jun 1, 2020 | Jun 2, 2020 | Vir Biotechnology, Inc. | CFO | Sell | 35.0 | -10,000 | -3.60% | ✓ | $351K |